Bevacizumab: all 1,786 studies that test it

Page 5 of 18. Open to participants first (285), then studies with results posted, then the rest; newest registration first within each.

• Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryCompletedNCT02292758Phase 2Results posted
• A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC)CompletedNCT02291289Phase 2Results posted
• Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung CancerCompletedNCT02272413Phase 3Results posted
• Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMDTerminatedNCT02214628Phase 2Results posted
• Bevacizumab Against Recurrent Retinal DetachmentCompletedNCT02192970Phase 2Results posted
• Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT02158520Phase 2Results posted
• A Study of Subcutaneous Bevacizumab in Relapsed / Progressive GlioblastomaCompletedNCT02157103Phase 2Results posted
• TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid TumorsActive, not recruitingNCT02142803Phase 1Results posted
• Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal CancerCompletedNCT02138617Phase 2Results posted
• Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Glioblastoma MultiformeCompletedNCT02120287Phase 2Results posted
• Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGFCompletedNCT02118831Phase 1/2Results posted
• A Study of Avastin (Bevacizumab) in Patients With Multiple MyelomaTerminatedNCT02079519Phase 2Results posted
• Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC PatientsCompletedNCT02069704Phase 1Results posted
• Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular EdemaCompletedNCT02036424Phase 4Results posted
• A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver CancerCompletedNCT02013830Phase 2Results posted
• A Multi-Center Study of the Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant SurvivalCompletedNCT01996826Phase 1/2Results posted
• Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)CompletedNCT01969708Phase 3Results posted
• Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT01966003Phase 3Results posted
• Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast CancerCompletedNCT01959490Phase 2Results posted
• Diabetic Macular Edema Treated With Ozurdex (DMEO)CompletedNCT01951066Phase 2Results posted
• Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryCompletedNCT01950390Phase 2Results posted
• Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell TumorsCompletedNCT01946529Phase 2Results posted
• Treatment for CI-DME in Eyes With Very Good VA StudyCompletedNCT01909791Phase 3Results posted
• Bevacizumab in Pats w/ Recurrent ST Brain Metas Who Have Failed Whole Brain Radiation TherapyCompletedNCT01898130Phase 2Results posted
• NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent GlioblastomaCompletedNCT01894061Phase 2Results posted
• Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal CancerTerminatedNCT01871571Phase 2Results posted
• Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment.CompletedNCT01860586Not applicableResults posted
• Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic RetinopathyCompletedNCT01854593Phase 4Results posted
• Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid TumorsCompletedNCT01831089Phase 1Results posted
• Abraxane/BevacizumabTerminatedNCT01821859Phase 2Results posted
• Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBMCompletedNCT01811498Phase 1/2Results posted
• Efficacy of Bevacizumab (Avastin) in Treatment of Acute NMO ExacerbationsCompletedNCT01777412Phase 1Results posted
• Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular SchwannomasCompletedNCT01767792Phase 2Results posted
• A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung CancerCompletedNCT01763645Phase 3Results posted
• A Phase II Study of Pulse Reduced Dose Rate Radiation Therapy With BevacizumabTerminatedNCT01743950Phase 2Results posted
• Bevacizumab Beyond Progression (BBP)CompletedNCT01740258Phase 2Results posted
• Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma PatientsCompletedNCT01738646Phase 2Results posted
• Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal CancerCompletedNCT01722162Phase 2Results posted
• Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal CancerCompletedNCT01718873Phase 3Results posted
• A Study of Bevacizumab Plus 5-Flurouracil (5-FU) Based Doublet Chemotherapy as Neoadjuvant Therapy for Participants With Previously Untreated Unresectable Liver-Only Metastases From Colorectal CancerCompletedNCT01695772Phase 4Results posted
• Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney CancerCompletedNCT01664182Phase 2Results posted
• Bloodstream Absorption of Avastin and Lucentis After Injection Into the EyeCompletedNCT01661946Phase 3Results posted
• Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung CancerCompletedNCT01661790Phase 3Results posted
• SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath TumorsCompletedNCT01661283Phase 2Results posted
• Bevacizumab in Treating Patients With Relapsed Prostate Cancer That Did Not Respond to Hormone TherapyCompletedNCT01656304Phase 2Results posted
• Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular EdemaCompletedNCT01627249Phase 3Results posted
• Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal CancerCompletedNCT01622543Phase 2Results posted
• Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal CarcinomaCompletedNCT01621880Phase 2Results posted
• Ranibizumab and Bevacizumab for Diabetic Macular EdemaCompletedNCT01610557Phase 2Results posted
• Pharmacokinetics and Safety Study of BI 695502 in Healthy SubjectsCompletedNCT01608087Phase 1Results posted
• A Translational Study of Bevacizumab in Participants With Metastatic Colorectal CancerCompletedNCT01588990Phase 4Results posted
• An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored StudyCompletedNCT01588184Phase 4Results posted
• Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent GliomaCompletedNCT01580969Phase 1/2Results posted
• Ozurdex for Treatment of Recalcitrant Diabetic Macular EdemaCompletedNCT01571232Phase 2Results posted
• A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With GlioblastomaCompletedNCT01564914Phase 2Results posted
• BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)CompletedNCT01562028Phase 2Results posted
• Salvage Ovarian FANG™ Vaccine + BevacizumabCompletedNCT01551745Phase 2Results posted
• Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor MutationsCompletedNCT01532089Phase 2Results posted
• Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine TumorsCompletedNCT01525082Phase 2Results posted
• Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant MelanomaTerminatedNCT01495988Phase 2Results posted
• Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal CancerCompletedNCT01481545Phase 2Results posted
• Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent GliomasTerminatedNCT01478321Phase 2Results posted
• A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent GlioblastomaCompletedNCT01474239Phase 2Results posted
• Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)CompletedNCT01454102Phase 1Results posted
• North American Study of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01408030Phase 2Results posted
• Submucosal Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01402531Phase 2Results posted
• Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Carcinoma (RCC)CompletedNCT01399918Phase 2Results posted
• Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01397695Phase 2Results posted
• A Study of Bevacizumab (Avastin) in Combination With Temozolomide (TMZ) and Radiotherapy in Paediatric and Adolescent Participants With High-Grade GliomaCompletedNCT01390948Phase 2Results posted
• A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal CancerCompletedNCT01383707Phase 2Results posted
• A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)CompletedNCT01351415Phase 3Results posted
• Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma MultiformeCompletedNCT01349660Phase 1/2Results posted
• Carboplatin, Pemetrexed Disodium, and Bevacizumab for Patients With Stage III or IV Non-Small Cell Lung Cancer Who Are Light/Never SmokersCompletedNCT01344824Phase 2Results posted
• Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is IndicatedCompletedNCT01332721Phase 1Results posted
• A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRITerminatedNCT01322815Phase 2Results posted
• Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal CancerTerminatedNCT01320683Phase 2Results posted
• Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral CavityCompletedNCT01296815Phase 2Results posted
• Carboplatin and Bevacizumab for Recurrent EpendymomaCompletedNCT01295944Phase 2Results posted
• Effect of Ozurdex® 0.7 mg on Improvement of Efficacy of Bevacizumab for Central Retinal Vein OcclusionCompletedNCT01295112Phase 2/3Results posted
• Amgen 386 for Recurrent GlioblastomaCompletedNCT01290263Phase 1/2Results posted
• Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal CancerTerminatedNCT01280643Not applicableResults posted
• Avastin for PDR (Proliferative Diabetic Retinopathy)CompletedNCT01270542Not applicableResults posted
• BATTLE-FL: Front-Line Biomarker-Integrated Treatment Study in Non Small Cell Lung CancerCompletedNCT01263782Phase 2Results posted
• A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian CancerCompletedNCT01239732Phase 3Results posted
• Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by SurgeryCompletedNCT01229943Phase 2Results posted
• A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.CompletedNCT01227707Phase 2Results posted
• Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory RhabdomyosarcomaCompletedNCT01222715Phase 2Results posted
• Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary OvarianCompletedNCT01219777Phase 1Results posted
• Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal TumorsCompletedNCT01217437Phase 2Results posted
• A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic CancerCompletedNCT01214720Phase 3Results posted
• Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach CancerCompletedNCT01212822Phase 2Results posted
• Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma MultiformeCompletedNCT01209442Phase 2Results posted
• Bevacizumab, Capecitabine, and Oxaliplatin in Treating Advanced Small Intestinal or Ampulla of Vater AdenocarcinomaCompletedNCT01208103Phase 2Results posted
• Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)CompletedNCT01207687Phase 2Results posted
• The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System TumorsTerminatedNCT01201850Not applicableResults posted
• A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast CancerCompletedNCT01201265Phase 2Results posted
• High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal CancerTerminatedNCT01198548Phase 2Results posted
• Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line TherapyTerminatedNCT01198158Phase 3Results posted
• CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric CancerCompletedNCT01191697Phase 2Results posted
• Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)TerminatedNCT01186406Phase 2Results posted

← Bevacizumab overview